Drug Shortage Report for VIOKACE

Last updated on 2022-12-23 History
Report ID 173999
Drug Identification Number 02241933
Brand name VIOKACE
Common or Proper name pancrelipase
Company Name NESTLE ENTERPRISES S.A.
Market Status MARKETED
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 113400UNIT 112500UNIT 20880UNIT
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 tablet bottles
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-11-08
Actual start date 2022-11-08
Estimated end date Unknown
Actual end date 2022-12-22
Shortage status Resolved
Updated date 2022-12-23
Company comments Drug product is being released today.
Health Canada comments
Tier 3 Status No
Contact Address 12, RUE ENTRE-DEUX-VILLES
VEVEY, --
SWITZERLAND 1800
Company contact information kfeltmate@apcipharma.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-12-23 English Compare
v7 2022-12-22 French Compare
v6 2022-12-22 English Compare
v5 2022-12-22 French Compare
v4 2022-12-22 English Compare
v3 2022-11-09 English Compare
v2 2022-11-08 French Compare
v1 2022-11-08 English Compare

Showing 1 to 8 of 8